Therapeutic group for women on the autism spectrum

Completed

• Conditions: Metal health and autism spectrum conditions; Mental and Behavioural Disorders

• Registration Number: ISRCTN13900653
• Lead Sponsor: Psicon Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-01-10
• Study Completion: 2018-04-30
• Last Update Posted: 5 November 2018

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

1. Female
2. With a diagnosis of Autism Spectrum Condition
3. Aged 18-65 years
4. Any racial and cultural background and any religious belief or sexuality

Exclusion Criteria

1. Men
2. Those without ASD diagnosis
3. Those not referred to Psicon
4. Those that present 'at risk' after initial risk assessment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Anxiety will be measured using the Generalised Anxiety Disorder 7-item scale (GAD-7) at baseline and 6 weeks<br>2. Depression and low mood will be measured using the Patient Health Questionnaire 9-item (PHQ-9) at baseline and 6 weeks<br>3. Self-esteem will be measured using the Rosenberg Self-Esteem Scale at baseline and 6 weeks<br>4. Any trauma will be measured using the Impact of Events Scale - Revised at baseline and 6 weeks

Secondary Outcome Measures

Name	Time	Method
General quality of life and experienced strengths and difficulties will be measured using the CORE-10, World Health Organisation Quality of Life Scale and Strengths and Difficulties Questionnaire at baseline and 6 weeks.